Abstract: 2, N-acetyl (6), N-alkyl (9) and fused pyrimidines (7, 8 
Ι. Introduction
Because of their interesting biological activities, low molecular weight heteroycles have attracted enormous attention in medicinal chemistry. Nitrogen-containing heterocycles have recently received a significant importance because of their diverse pharmacological properties [1] [2] [3] [4] [5] . Of these heterocycles, the synthesis, reactions and biological activities of pyrimidine containing molecules stands as an ever expanding area of research in hetero aromatic chemistry. However, the synthesis of some substituted pyrimidines by the treatment of α,β-unsaturated esters with thiourea and guanidine in the presence of anhydrous potassium carbonate were reported [6] . The literature indicated that compounds having pyrimidine nucleus possesses broad range of biological activity like anticancer, antiviral, anti-HIV, antibacterial, antihypertensive, anticonvulsant, antithyroid, and antibiotics [7] .The electron Impact (EI) ionization mass spectral fragmentation of some of the synthesized 2-aminopyrimidine and 2-mercaptopyrimidine derivatives were described.
II.
Results and Discussion
1) Chemistry
Condensation of 3-bromo-4-methoxybenzaldehyde (1) with ethylcyanoacetate in the presence of anhydrous potassium carbonate led to the formation of ethyl β-(3-bromo-4-methoxyphenyl)-α-cyanoacrylate (2) . The reaction of ester derivative (2) with guanidine hydrochloride and thiourea in methanol in presence of anhydrous potassium carbonate under reflux, yielded the corresponding 6-(3-bromo-4-methoxyphenyl)-5-cyano-4-hydroxy-2-aminopyrimidine (3) and 6-(3-bromo-4-methoxyphenyl)-5-cyano-4-hydroxy-2-mercaptopyrimidine (4, Scheme 1).
Treatment of 2-mercaptopyrimidine (4) with 4-methylphenacyl bromide in presence of fused sodium acetate in acetic acid under reflux afforded the corresponding 6-(3-bromo-4-methoxyphenyl)-5-cyano-4-oxo-3-(p-methylphenyl)-thiazolo [2,3- 
Synthesis, Mass Spectra Investigation and Biological Activity of Some Pyrimidine Derivatives
Acetylation of 2-aminopyrimidine (3) with acetic anhydride under reflux led to the formation of 6-(3-bromo-4-methoxyphenyl)5-cyano-4-hydroxy-2-(acetylamino)pyrimidine (6) . Treatment of 2-aminopyrimidine (3) with ethylchloroacetate in acetic acid afforded the corresponding 6-hydroxy-5-cyano-4-imidazolidino[2,1-b] pyrimidin-3-one (7). The reaction of methyl acrylate in dimethylformamide in presence of fused sodium acetate gave the corresponding 5-(3-bromo-4-methoxyphenyl)-6-cyano-7-hydroxy-2,3-dihydropyrimidino[2,1-b]pyrimidin-4-one (8) . Alkylation of 2-aminopyrimidine (3) with 4-methylphenacylbromide in acetic acid under reflux yielded the corresponding 2-(p-methylbenzoyl)methylamino-4-hydroxy-5-cyano-6-(3-bromo-4-methoxyphenyl)pyrimidine (9, Scheme 2).
2) Mass Spectrometry
The mass spectral decomposition modes [6] [7] [8] [9] [10] of the prepared 2-mercaptopyrimidine and 2-aminopyrimidine derivatives have been investigated. Table 1 lists the m/z (relative abundance, %) values of the principle fragment of synthesized compounds, while figures 1,2,3,4,5 and 6 illustrated the mass spectra of compounds 3,4,5,6,8 and 9 respectively.
Compound 3
The mass spectrum of compound 3 ( Fig.1) showed the molecular ion peaks at m/z 320/322 corresponding to the molecular formula C 12 H 9 N 4 BrO 2 . The base peaks of compounds 3 was found at m/z 322 (M+2) along with the molecular ion peak due to the presence of isotope of bromine atom present in this compounds. The molecular ion of compound 3 fragmented further and involved two pathways as illustrated in table 1 (Scheme 3). The molecular ion of m/z 320 fragmented via pathway A to give peak at m/z 279 by losing NH-CN group. The peak at m/z 279 underwent fragmentation to produce a peak at m/z 212. It further underwent loss of NH, HBr, C 2 and CH 2 O to give peaks at m/z 197, 117, 93 and m/z 63 respectively. Accordingly, the same molecular ion of m/z 320 fragmented via the pathway B by the cleavage of isocyanate group (NCO) to give peak at m/z 278, which lose NH-CN group to give a peak at m/z 237. Then lose of formaldehyde and bromine atom to a peak at m/z 128. It further underwent loss of CH=CHN molecule to give a peak at m/z 76.
Compound 4:
The mass spectrum of compound 4 ( Fig. 2) showed the molecular ion peak at m/z 337/339 corresponding to the molecular formula C 12 H 8 N 3 BrO 2 . The base peak of compounds 4 was found at 339 (M+2). Fig. 6 ) shows relatively small molecular ions peaks typical of a cleavage and rearrangement processes type fragmentation. From the study of the mass spectra of compounds 6, 8 and 9, it was found that the molecular ion for all these compounds fragmented further and involved two various pathways as illustrated by Table 1 . 
III.
Biological activity 1) Antimicrobial activity Using paper disc agar diffusion technique [11, 12] all the newly synthesized compounds were tested in vitro for antibacterial activity against sever at strains of bacteria such as Bacillus subtilis, Straphylocouus aureas, Streptococcus pneumonia, Escherichia coli and Pseudomonas solanarium. Also these compounds were tested in vitro against some fungi such as Aspergillus Nigar and Penicillium. The selectivity of compounds 3, 4, 5, 6 and 9 were tested at 100µg/ml concentration and the activity was determined by measuring Zone of inhibition. The screening results given in Table 2 indicated that all the compounds exhibited antibacterial and antifungal activities against one or the other type of bacteria and fungi. From the results obtained, it is clear that compound 3 showed mild activity against the tested bacteria and fungi. Compound 4 showed high activity toward the test bacteria and moderate activity toward the tested fungi. Compounds 5 and 9 showed moderate activity against the test bacteria and high activity against the tested fungi. Compound 6 showed moderate activity towards both the test bacteria and fungi. 
2) Anticancer evaluation
The cytotoxicity and antitumor activity of the prepared compounds 3, 4, 5 and 6 wereevaluated of cytotoxicity against MCF-7 cell line according to the method of Masmann [13] and Vrjayen [14] . Inhibitory activity against Breast carcinoma cells (MCF-7 cell line) was detected by using different concentrations of the tested compounds from (0-50 µg) and viability % was detected. Also, inhibitory concentration fifty (IC 50 ) for compounds 3, 4, 5 and 6 were calculated from figures 7-10 respectively. Inhibitory activity concentrations fifty (IC 50 ) detected under the experimental conditions were to be 9.5µg for compound 6, 10.42 for compound 3, 11.8 µg for compound 5 and 17.1 µgfor compound 4. These results revealed that, all the tested compounds have cytotoxic and antitumor activities against Breast carcinoma cells with superiority of the prepared compound 6 with inhibitory concentration fifty (IC 50 ) equal to 9.5µg. 
IV. Experimental
Melting points were determined in capillaries with a Thomas-Hover Uni-Melt apparatus and are uncorrected. Infrared spectra were taken on a Perkin-Elmer 1420 spectrometer and a Biorad FTS7 (KBr). Proton NMR spectra were recorded on a general electric QE 300 instrument and chemical shifts are given with respect to TMS. Mass spectra were recorded on a Jeol JMS D-300 spectrometer operating at 70 eV. Microanalyses were conducted using an elemental analyzer 1106.
Ethyl-β-(3-bromo-4-methoxyphenyl)-α-cyanoacrylate (2)
A mixture of 3-bromo-4-methoxybenzaldehyde (0.01 mole), ethyl cyanoacetate (0.01 mole) and anhydrous potassium carbonate (0.03 mole) in methanol (50 ml) was heated under reflux for 2hrs, then cooled and poured into water. The resulting solid was filtered off, washed with water, dried and purified with ethanol to give 2 as colorless crystals, yield 87% 
6-(3-Bromo-4-methoxyphenyl)-5-cyano-4-hydroxy-2-substituted-pyrimidines (3 and 4)
A mixture of 2 (0.01 mole), guanidine hydrochloride or thiourea (0.01mole) in methanol (50 ml) in presence of anhydrous potassium carbonate (0.03 mole) was heated under reflux for 4 hrs, then cooled and poured into icedilute hydrochloric acid (1N). The resulting solid was filtered off, washed with water, dried and purified by recrystallization from suitable solvent to give 3 and 4. 
6-(3-Bromo-4-methoxyphenyl)-5-cyano-4-hydroxy-2-amino-pyrimidine(3)

6-(3-Bromo-4-methoxyphenyl)-5-cyano-3-(p-tolyl)-thiazolo-[3,2-b]-pyrimidin-4-one (5)
A mixture of 4 (0.01 mole) and 4-methyl phenacylbromide (0.01 mole) in acetic acid (30 ml) in presence of fused sodium acetate (0.03 mole) was heated under reflux for 4 hrs, then cooled and poured into water. The crude product obtained was filtered off, washed with water, dried and purified by recrystallization from ethanol to give 5 Bromo-4-methoxyphenyl)-5-cyano-3-hydroxy-2-acetylamino)-pyrimidine (6) A solution of 3 (0.01 mole) in acetic anhydride (20 ml) was refluxed for 2 hrs., then cooled and poured into icewater. The solid obtained was filtered off, washed with water, dried and purified by ethanol to give 6 
6-(3-
6-Hydroxy-5-cyano-4-(3-bromo-4-methoxyphenyl)-imidazolidino-[2,1-b]-pyrimidin-3-one (7)
A mixture of 3 (0.01 mole) and ethyl chloroacetate (0.01 mole) and fused sodium acetate (0.03 mole) in acetic acid (30 ml) was heated under reflux for 4 hrs, then cooled and poured into ice-water. The crude product obtained was filtered off, washed with water, dried and purified by recrystallization from ethanol to give 7 as a yellow crystals, yield 62% 
7-Hydroxy-6-cyano-5-(3-bromo-4-methoxyphenyl)-2,3-dihydropyrimidino[2,1-b]-pyrimidin-4-one (8)
A mixture of 3 (0.01 mole), methyl acrylate (0.01 mole) and fused sodium acetate (0.03 mole) in dimethylformamide (25 ml) was refluxed for 6 hrs, then cooled and poured into ice-water. The resulting solid was filtered off, washed with water, dried and purified by recrystallization from acetic acid to give 8 
2-(P-methylbenzoyl)methylamino-5-cyano-6-(3-bromo-4-methoxyphenyl)-4-hydroxy-pyrimidine (9)
A mixture of 3 (0.01 mole) and 4-methyl-phenylacylbromide (0.01 mole) in acetic acid (25 ml) was refluxed for 2 hrs, then cooled and poured into ice-water. The solid formed was filtered off, washed with water, dried and purified by recrystallization from ethanol to give 9 as a yellow crystals, yield 67% 
